Erin M. Odor, MA, CIP (she/her/hers)

Advarra
Columbus, OH

Erin M. Odor, MA, CIP, joined Advarra as a full-time IRB chairperson in May 2022 and provides regulator expertise on FDA-regulated medical device research. Previously, Erin served as a quality improvement specialist for regulatory, education, and policy analysis at Ohio State University’s Office of Responsible Research Practices. In that role, she established an internal QI assessment program of IRB operations, delivered educational presentations to the research community, and co-authored a university-wide policy governing the use of protected health information in research. She also served on the university’s conflict of interest advisory committee and privacy board. A Certified IRB Professional, Erin co-teaches courses for PRIM&R, including an Advanced FDA Regulations workshop, serves as a co-chair of this year's PRIM&R Annual Conference Poster Abstract Sub-Committee, and has contributed articles to blogs such as Ampersand.

Presentation(s):

• B02 - When SBER Meets FDA: A Survival Guide to Support SBE IRBs and Researchers

  Thursday, November 6, 2025
  11:30 AM - 12:30 PM ET

• PRIMR25 Poster Presentation—Enhancing Post-Approval Monitoring: A Gap Analysis Approach to Foster Collaboration Among Regulatory Research Stakeholders

  Friday, November 7, 2025
  12:30 PM - 12:50 PM ET